They quote p=0.179 for the OS results so, according to my basic understanding of statistics, this can't constitute evidence that sorafenib is superior. All other quoted results favour SIRT and are statistically significant. Look at the side-effect/quality of life result (p=0.005)! To me, this shows that SIRT is by far the better treatment. IMHO (Not a statistician or medico).
Ann: Trading Halt, page-38
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.74M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 18.0¢ | $10.1K | 56.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36209025 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 4384259 | 22 |
View Market Depth
| Last trade - 15.18pm 13/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |